Cost-Effectiveness of IDegAsp in Diabetes Manag...

By Melike Belenli Gümüş

June 24, 2024

Introduction Type 2 diabetes impacts over 500 million individuals globally, leading to substantial healthcare cost...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Economic Benefits of Preventive Health Programs
The Shift to Value-Based Drug Pricing in the United States
Brucellosis Control in Armenia: A Holistic Approach
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Advancing Pneumococcal Disease Prevention in Japan with PCV20
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Self-Management of Vaginal Pessaries: A Viable Alternative for Pelvic Organ P...
Treatment Effect Estimation with AI: The CURE Framework